Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Curnutte John T Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc
Txns: Granted 105,000 options to buy @ $0.495, valued at $52k
06/08/2023 4 Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/21/2022 4 Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $6.8, valued at $102k
06/08/2022 4 Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc
Txns: Granted 46,000 options to buy @ $0.4747, valued at $21.8k
06/30/2021 4 Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 13,286 options to buy @ $28.2, valued at $374.7k
06/17/2021 4 Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc
Txns: Granted 40,000 options to buy @ $4.79, valued at $191.6k
06/19/2020 4 Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc
Txns: Granted 35,000 options to buy @ $7.81, valued at $273.4k
05/21/2019 4 Curnutte John T (EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 4,688 shares @ $0
Granted 1,750 shares @ $0
Paid exercise price by delivering 2,418 shares @ $28.69, valued at $69.4k
Paid exercise price by delivering 903 shares @ $28.69, valued at $25.9k
Exercised 4,688 rights @ $0
03/05/2019 4 Curnutte John T (EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 6,446 shares @ $33.41, valued at $215.4k
02/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/15/2019 4 Curnutte John T (EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 1,750 shares @ $0
Paid exercise price by delivering 715 shares @ $24.25, valued at $17.3k
09/05/2018 4 Curnutte John T (Interim Co-President & EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Exercised 17,500 shares @ $0
Paid exercise price by delivering 8,884 shares @ $29.1764, valued at $259.2k
08/28/2018 4 Curnutte John T (Interim Co-President & EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Exercised 17,500 shares @ $0
Paid exercise price by delivering 8,171 shares @ $26.05, valued at $212.9k
05/24/2018 4 Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 4,687 shares @ $0
Paid exercise price by delivering 1,647 shares @ $40.82, valued at $67.2k
03/14/2018 4 Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Exercised 5,049 options to buy @ $8.5, valued at $42.9k
03/06/2018 4 Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 4,530 shares @ $32.53, valued at $147.4k
02/02/2018 4 Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 8,750 shares @ $0
Granted 35,000 options to buy @ $51.31, valued at $1.8M
09/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/01/2017 4 Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 12,500 shares @ $0
Granted 50,000 options to buy @ $25.54, valued at $1.3M
Granted 12,500 rights @ $0
05/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/04/2016 4 Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,271 shares @ $31.75, valued at $40.4k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy